CICALA, MICHELE
 Distribuzione geografica
Continente #
AS - Asia 8.145
NA - Nord America 3.164
EU - Europa 1.464
SA - Sud America 372
AF - Africa 79
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 13.259
Nazione #
SG - Singapore 5.990
US - Stati Uniti d'America 3.016
CN - Cina 1.138
IT - Italia 660
HK - Hong Kong 523
GB - Regno Unito 251
BR - Brasile 249
FR - Francia 190
VN - Vietnam 176
DE - Germania 121
IN - India 90
CA - Canada 70
MX - Messico 55
AR - Argentina 45
NL - Olanda 38
FI - Finlandia 33
BD - Bangladesh 32
AU - Australia 31
JP - Giappone 28
ZA - Sudafrica 28
ID - Indonesia 27
ES - Italia 21
CZ - Repubblica Ceca 20
TR - Turchia 20
CO - Colombia 18
UA - Ucraina 18
PK - Pakistan 17
PL - Polonia 17
RU - Federazione Russa 15
EC - Ecuador 14
IQ - Iraq 14
VE - Venezuela 13
SE - Svezia 12
AT - Austria 11
BE - Belgio 11
MY - Malesia 10
PH - Filippine 10
CL - Cile 8
PE - Perù 8
PY - Paraguay 8
SA - Arabia Saudita 8
EG - Egitto 7
MA - Marocco 7
BO - Bolivia 6
ET - Etiopia 6
GR - Grecia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
JO - Giordania 5
KZ - Kazakistan 5
NP - Nepal 5
RO - Romania 5
TH - Thailandia 5
TN - Tunisia 5
AZ - Azerbaigian 4
CH - Svizzera 4
HU - Ungheria 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
LU - Lussemburgo 3
OM - Oman 3
PR - Porto Rico 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DM - Dominica 2
GA - Gabon 2
IE - Irlanda 2
JM - Giamaica 2
KH - Cambogia 2
LY - Libia 2
NG - Nigeria 2
PT - Portogallo 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HN - Honduras 1
Totale 13.232
Città #
San Jose 1.104
Singapore 761
Ashburn 697
Hong Kong 511
Rome 494
Hefei 371
Beijing 304
Boardman 217
London 217
Lauterbourg 167
Dallas 141
Shanghai 128
Council Bluffs 82
Ho Chi Minh City 78
Los Angeles 68
Santa Clara 54
Munich 49
New York 46
San Francisco 42
West Jordan 40
Mexico City 36
Pune 34
Washington 33
Hanoi 30
Amsterdam 27
São Paulo 27
Seattle 26
Turku 23
Toronto 19
Burlington 18
Sona 18
Brooklyn 16
Orem 16
Tokyo 16
Frankfurt am Main 14
Warsaw 14
Chennai 13
Boston 12
Brno 12
Buffalo 12
Charlotte 12
Chicago 12
Montreal 12
Melbourne 11
Helsinki 10
Milan 10
Rio de Janeiro 10
Stockholm 10
Brussels 9
Canberra 9
Johannesburg 9
Paris 9
Buenos Aires 8
Bogotá 7
Curitiba 7
Guangzhou 7
Haiphong 7
Manchester 7
Olomouc 7
Phoenix 7
Asti 6
Athens 6
Chengdu 6
Guarulhos 6
Pastorano 6
Quito 6
Secaucus 6
Surabaya 6
Sydney 6
Amman 5
Atlanta 5
Da Nang 5
Dhaka 5
Hanover 5
Lahore 5
Markham 5
Mumbai 5
Narni 5
San Juan 5
Vienna 5
Addis Ababa 4
Baghdad 4
Bangkok 4
Berlin 4
Cape Town 4
Caracas 4
Catania 4
Denver 4
Hamburg 4
Hyderabad 4
Istanbul 4
Kuala Lumpur 4
Lima 4
Medellín 4
Messina 4
Ninh Bình 4
Rimini 4
Riyadh 4
Tashkent 4
Tianjin 4
Totale 6.356
Nome #
Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms 244
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 238
Early impairment of food intake in patients newly diagnosed with cancer 235
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure 234
Effect of hypothermia on human colonic smooth muscle contractility 233
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 225
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 222
DECREASED NUMBER OF ACTIVATED MACROPHAGES IN GALLBLADDER MUSCLE LAYER OF CHOLESTEROL GALLSTONES PATIENTS FOLLOWUING URSODEOXYCHOLIC ACID 220
EFFECTS OF THERMAL COOLING ON HUMAN COLONIC SMOOTH MUSCLE CONTRACTILITY 216
Impaired Human Colonic Contractility and Toll-Like Receptor 4 (TLR4) Expression in Uncomplicated Diverticular Disease 215
Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. 210
Clinical impact of proton pump inhibitor response and dependence 208
Effect of the gatekeeper reflux repair system on intra-esophageal distribution of acid reflux in gastroesophageal reflux disease patients: Relation with typical symptoms 208
IMPAIRED HUMAN COLONIC CONTRACTILITY AND TOLL-LIKE RECEPTOR 4 (TLR4) EXPRESSION IN UNCOMPLICATED DIVERTICULAR DISEASE 206
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 204
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 194
Association between dietary habits and fecal microbiota composition in irritable bowel syndrome patients: A pilot study 144
Activated muscularis macrophages contribute to muscle cell dysfunction in cholesterol gallstone patients 141
Achalasia, from diagnosis to treatment 140
Chicago Classification v4.0 Stratifies Acid Burden and Abnormal Impedance-pH Variables Better Than Chicago Classification v3.0 Chicago Classification v4.0 and GERD 137
Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms 136
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 135
Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells 131
Anxiety correlates with excessive air swallowing and PPI refractoriness in patients with concomitant symptoms of GERD and functional dyspepsia 130
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy 130
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 127
Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review 125
Effect of Inulin on Proteome Changes Induced by Pathogenic Lipopolysaccharide in Human Colon 121
Asymptomatic parasitic infection in a Crohn's disease patient on anti-TNFα therapy: an alert for our patients? 121
Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid 120
Gastrointestinal sensitivity and gastroesophageal reflux disease 118
Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients 117
Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux 114
Antioxidant activity of Inulin and its role in the prevention of human colonic muscle cell impairment induced by Lipopolysaccharide mucosal exposure 113
Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease 113
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 112
Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients 111
Esophageal disease: updated information on inflammation 106
Experimental evidence and mathematical modeling of thermal effects on human colonic smooth muscle contractility 104
Esophageal pH increments associated with post-reflux swallow-induced peristaltic waves show the occurrence and relevance of esophago-salivary reflex in clinical setting 101
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 96
Gastro-esophageal reflux disease and Obesity, where is the link? 95
Gastroesophageal reflux disease: Update on inflammation and symptom perception 93
Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress 93
Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease 89
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 85
Impaired colonic contractility and intestinal permeability in symptomatic uncomplicated diverticular disease 84
Diarrhea predominant-irritable bowel syndrome (Ibs-d): Effects of different nutritional patterns on intestinal dysbiosis and symptoms 84
Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date 74
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study 68
Palmitic acid affects intestinal epithelial barrier integrity and permeability in vitro 68
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 67
Psychological distress in inflammatory bowel disease 67
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 65
Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21(waf-1), p27, and PCNA in Barrett's esophagus 64
Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics 64
Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD 64
HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells 63
Esophageal chest pain resembles heartburn in reflux metrics and response to proton pump inhibitor therapy 59
A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring 59
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 58
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 57
48-Hour Monitoring Significantly Increases Diagnostic Yield of Multichannel Intraluminal pH-Impedance in Non-Erosive Reflux Disease Patients 57
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones 56
High Resolution Manometry Findings Do Not Predict Bolus Clearance of Saline Swallows in Patients With Non-Obstructive Dysphagia 56
A health technology-related cost description concerning italian IBD centres dealing with Crohn's disease results from SOLE study 56
Protective Role of Natural Compounds under Radiation-Induced Injury 55
Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage. 55
Safety and tolerability of a novel oral nutritional supplement in healthy volunteers 55
Natural Compounds with Antimicrobial Activities in Oral Candida Infections during Head and Neck Radiotherapy 54
Effect of spasmodil complex on bile flow. Double-blind controlled study 54
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 54
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 54
Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients 53
Antro-pyloric contractile patterns and transpyloric flow after meal ingestion in humans 53
Human Colonic Smooth Muscle Contractility Following Acute Thermal Cooling 53
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease 52
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls 52
Adalimumab in active ulcerative colitis: A "real-life" observational study 52
Expression of GH/IGF-1 Axis Compounds in Moderate-Severe Crohn's Disease: Role of Mucosal Inflammation and Anti TNF-alpha Treatment 52
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. 52
A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders 51
Complementary and alternative medicine in irritable bowel syndrome: a survey amongst italian gastroenterologists 51
Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed 50
Early-onset versus late-onset Crohn's disease: An Italian cohort study 50
Baseline impedance levels and structural and functional integrity of the esophageal mucosa: is acid still the only player? 50
ULTRASONOGRAPHIC ASSESSMENT OF GALLBLADDER (GB) BILE TURNOVER BEST INDICATES THE DEFECTIVE GB EFFICIENCY IN GALLSTONES PATIENTS 49
Ultrasonographic assessment of gallbladder bile exchanges in healthy subjects and in gallstone patients 48
ULTRASONOGRAPHIC ASSESSMNENT OF GALLBLADDER BILE EXCHANGES IN HEALTHY SUBJECTS AND IN GALLSTONES PATIENTS 48
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 48
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 48
Exploring the genetic diversity of the 16S rRNA gene of Akkermansia muciniphila in IBD and IBS 47
Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease 47
Associations between the IGF system and inflammatory markers in inflammatory bowel disease 47
Effect of endogenous cholecystokinin on postprandial gallbladder refilling. Ultrasonographic study in healthy subjects and in gallstone patients 47
Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world 47
Dilated intercellular space diameter as marker of reflux-related mucosal injury in children with chronic cough and gastro-oesophageal reflux disease 47
High fat consumption in children with celiac disease 46
Impact of Weight Loss on Surgical Outcomes in Resectable Pancreatic Cancer Patients Undergoing Pancreaticoduodenectomy (PD) 46
Gastrointestinal neuromuscular apparatus: an underestimated target of gut microbiota 46
Totale 10.013
Categoria #
all - tutte 89.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022273 0 0 4 9 3 4 0 9 6 5 1 232
2022/2023101 10 0 3 8 3 1 1 5 2 0 67 1
2023/2024836 30 77 69 55 75 350 9 62 5 55 31 18
2024/20256.676 83 71 259 46 112 159 117 22 541 437 2.142 2.687
2025/20265.440 580 342 280 592 249 310 1.706 410 496 475 0 0
Totale 13.326